
In April 2024, Blaize Inc. secured $106.0M in funding, marking one of the largest US startup funding rounds. Biotech and health companies have amassed approximately $5.6B across 110 Series A rounds in 2024, comprising 53% of all Series A funding. U.S. startups have seen a rise in rounds exceeding $100 million this year, with 115 such rounds recorded by mid-May, a 58% increase from the previous year.
Rounds of $100 million or more have surged this year, with U.S. startups securing 115 such rounds through mid-May, a 58% increase from the 73 raised last year, with biotech and artificial intelligence among the industries benefiting the most. https://t.co/2ULcwIZMg4
[Published in May 2024] 📈💰 Stay updated on the latest startup funding activities with our weekly roundup 💼✨ Check out the top 10 investment deals in Asia, including Meesho's impressive $275 million raise: https://t.co/WhkbSlGthe
The week was much quieter than the past few when it came to big funding deals for U.S. startups, but still saw a big $1 billion raise go to (what else?) an AI startup. Biotech and blockchain also saw some good-sized raises. https://t.co/xz0WQDSg5Z






